Skip to main content
. 2025 Apr 11;16:1574679. doi: 10.3389/fphar.2025.1574679

TABLE 4.

Changes in Serum alkaline phosphatase (ALP) Relative to Baseline After 12 Weeks of Treatment in three groups.

Group Baseline Week 12 χ 2 P value
Mild Group (n = 20) 105.77 ± 31.66 85.44 ± 27.18 1.728 0.191
Moderate Group (n = 12) 122.19 ± 46.62 92.27 ± 28.94 2.210 0.123
Severe Group (n = 12) 190.81 ± 134.31b 132.58 ± 75.83ab 8.489 0.001

Note: Compared with Visit 3, a P < 0.05; compared with the mild group, b P < 0.05.